So, as you go into your 2026 renewal conversations, heres what you need to know about where GLP-1s stand, how they may affect employer plans, and the compliance questions you should help your clients think through
In phase 3 clinical trials, patients lost an average of 15 more pounds with tirzepatide than with a placebo and an average of 23 pounds more than the placebo group when they used tirzepatide and insulin
Khng phi ai cng c th s dng vin ung sng da, c bit l ph n c thai hoc ang cho con b v ngi mn cm vi cc thnh phn ca thuc
How to take Liposomal L-Glutathione and Vitamin C
Quick Answer: GLP-1 agonists are not currently approved or recommended for treating alcohol use disorder in the UK, though early research suggests potential effects on alcohol consumption via brain reward pathways
New-onset or worsening fatigue in established users warrants investigation for alternative causes, including thyroid dysfunction, anemia, vitamin deficiencies, or other medical conditions that may have developed independently of the medication